Occudo Quantitative Strategies LP Omeros Corp Transaction History

Occudo Quantitative Strategies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.09 - $7.46 $222,035 - $536,045	-71,856 Reduced 49.23%	74,100 $233,000
Q2 2022 Aug 15, 2022	BUY	$1.92 - $6.28 $200,117 - $654,551	104,228 Added 249.78%	145,956 $401,000
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $127,262 - $180,727	-25,101 Reduced 37.56%	41,728 $251,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $8.54 $182,052 - $274,202	32,108 Added 92.47%	66,829 $430,000
Q3 2021 Nov 15, 2021	BUY	$13.4 - $16.3 $210,420 - $255,958	15,703 Added 82.57%	34,721 $479,000
Q2 2021 Aug 16, 2021	SELL	$14.81 - $19.13 $51,731 - $66,821	-3,493 Reduced 15.52%	19,018 $282,000
Q1 2021 May 14, 2021	BUY	$14.52 - $23.53 $326,859 - $529,683	22,511 New	22,511 $401,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.